VIM and ovarian carcinoma: In addition, EMT biomarkers CDH1 and VIM were highly expressed in cancer cells, consistent with previous reports showing that TAM promoted EMT progress of cancers (lung cancer, colorectal cancer, breast cancer and ovarian cancer) by SPP1[64].